Drug recall · January 8, 2020
Bimatoprost Ophthalmic Solution recall
Why: Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.
- Lots / codes
Lot# H801686, Exp. 12/31/2019.
- Quantity
- 2,130 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide in the U.S.
- Initiated
- December 13, 2019 · Voluntary: Firm initiated
- Classified
- January 2, 2020
- Reported
- January 8, 2020
- Ended
- October 19, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bimatoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.